Table 5 Comparison of clinical profiles of HBsAg seropositive participants (unaware of hepatitis B versus aware of hepatitis B).

BMI ≥ 24 kg/m²

1.24(0.85–1.82)

0.262

1.18(0.79–1.76)

0.413

BMI ≥ 27 kg/m²

1.66(1.07–2.58)

0.024

1.85(1.17–2.92)

0.009

Metabolic syndrome

2.26(1.50–3.41)

<0.001

1.85(1.20–2.83)

0.005

Elevated blood pressure

1.57(1.06–2.30)

0.023

1.20(0.79–1.83)

0.391

Central obesity

2.65(1.79–3.92)

<0.001

2.33(1.56–3.49)

<0.001

Hypertriglyceridemia

1.60(1.00–2.58)

0.048

1.60(0.99–2.60)

0.057

Low HDL-C

1.40(0.90–2.21)

0.139

1.33(0.83–2.11)

0.234

Hyperglycemia

2.10(1.42–3.11)

<0.001

1.64(1.08–2.49)

0.020

Total cholesterol (≥200 mg/dL)

0.92(0.63–1.34)

0.646

0.89(0.64–1.31)

0.558

LDL-C (≥130 mg/dL)

0.93(0.63–1.36)

0.705

0.93(0.63–1.38)

0.713

HOMA-IR ≥ 1.9

2.21(1.51–3.25)

<0.001

2.15(1.45–3.20)

<0.001

Fatty liver

1.16(0.59–2.29)

0.668

1.17(0.59–2.31)

0.657

AST > 34 U/L

1.17(0.68–2.01)

0.583

1.10(0.63–1.93)

0.733

ALT > 36 U/L

0.98(0.59–1.61)

0.927

1.12(0.68–1.88)

0.673

APRI > 0.5

1.27(0.74–2.18)

0.381

1.14(0.65–1.99)

0.645

APRI > 1.0

2.61(0.62–11.04)

0.194

2.57(0.58–11.29)

0.212